Physician profile
Megan E Gardner
NPI 1548471832
$1,940.46
in general payments reported to CMS, 2019-2025
18 companies · $483 in 2025
The $483 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $50.95 · 2021: $159 · 2022: $111 · 2023: $439 · 2024: $484 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $653.27 | 2023-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $226.71 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $204.64 | 2023-2025 | Qelbree, Qelbree |
| Pfizer INC. | $168.86 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $127.51 | 2022-2024 | Jornay Pm |
| Tris Pharma INC | $124.68 | 2021-2024 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $79.70 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $78.85 | 2020-2021 | |
| Sanofi Pasteur INC. | $73.41 | 2021-2025 | |
| Glaxosmithkline, LLC. | $60.26 | 2019-2023 | Bexsero |
| Neos Therapeutics, LP | $30.83 | 2019 | |
| Hologic Sales and Service, LLC | $23.78 | 2022 | |
| Genentech USA, INC. | $19.48 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.50 | 2023 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $16.01 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.80 | 2019 | |
| Shire North American Group INC | $12.11 | 2019 | |
| Aytu Biopharma, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.